Related Experiment Videos
[Clinico-experimental studies on blood viscosity].
Summary
This study investigated blood viscosity in 144 patients post-surgery and infucoll 6% infusion. Elevated blood viscosity is linked to malignant tumors and respiratory diseases, with infucoll showing regulatory effects.
Area of Science:
- Medical Science
- Biomedical Engineering
Background:
- Surgical treatments can impact physiological parameters.
- Blood viscosity is a critical factor in various pathophysiological conditions.
- Malignant tumors and respiratory illnesses are associated with altered blood rheology.
Purpose of the Study:
- To evaluate blood viscosity changes after surgical treatment and infucoll 6% infusion.
- To explore the relationship between blood viscosity, malignant tumors, and respiratory system diseases.
Main Methods:
- Blood viscosity measurements were performed on 144 patients.
- The Höppler rheo-viscometer was utilized for comparative examinations.
- Infucoll 6% was administered to assess its rheological effects.
Main Results:
- A correlation was established between increased blood viscosity, malignant tumors, and respiratory system diseases.
- Infucoll 6% demonstrated discreet effects on coagulation and reduced blood viscosity.
- Infucoll 6% exhibited a notable hindrance of thrombocyte aggregation.
Conclusions:
- Blood viscosity is significantly influenced by malignant tumors and respiratory conditions.
- Infucoll 6% possesses a regulatory character, improving rheological parameters.
- The study highlights the therapeutic potential of infucoll in managing blood viscosity-related complications.